Brief: Toleranzia Completes GLP Toxicology Study Of TOL2
15/01/2024 09:03
Jan 15 (Reuters) - Toleranzia AB TOLE.ST :
* SUCCESSFULLY COMPLETES GLP TOXICOLOGY STUDY OF TOL2
* RESULTS DEMONSTRATE THAT TOL2 IS WELL TOLERATED AT DOSE
TESTED
Source text for Eikon: ID:nMFN70zZhl
Further company coverage: TOLE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Toleranzia AB
See all newsBrief: Swedish Companies Registration Office Permits Implementation of Flerie, Toleranzia's M&A
Brief: Toleranzia Q2 Net Income SEK -2.911 Million
Brief: Nasdaq Stockholm Approves Toleranzia’S Application For Delisting
Brief: Toleranzia Applies For Delisting Of Shares On Nasdaq
Brief: Toleranzia Approves Merger Plan Adopted By Boards Of Toleranzia, Flerie